Professor Victoria Allgar is Reader in Medical Statistics at Hull York Medical School / Department of Health Sciences, University of York.
Victoria has a joint appointment between Hull York Medical School and the Department of Health Sciences, University of York. Her work involves bringing together the knowledge of a range of experts from different specialisations to help identify and answer key research questions through the design and conduct new studies. Victoria provides statistical and project oversight of these studies.
She is Head of the Centre for Health and Population Sciences which brings together Hull York Medical School staff with expertise to address issues related to population health and healthcare. Research covers a broad range of topics including: statistics, epidemiology; adult and child mental health; evidence based practice, patient safety; global public health; and primary care.
Victoria is the Academic Lead for the MB BS assessment (Health and Society).
She is Chair of the Equality, Diversity and Inclusion Committee, Deputy Chair of the Exceptional Circumstances Committee and a member of the Ethics Committee.
Visit Victoria's profile on the University of York website
Victoria Allgar joined Hull York Medical School in 2006. She had previously worked at the Centre for Research in Primary Care, University of Leeds (2000-2006) as a Senior Research Fellow. Prior to this she worked as a Medical Statistician, Leeds Teaching Hospitals NHS Trust (1997-2000) and as a Research Associate, at the Department of Primary Health Care, University of Newcastle (1995-1997).
The following highlights the successfully funded research from 2010 to date:
1. Diagnosis and Management of venous thromboembolism (VTE) in patients with advanced cancer: how do physicians decide? RfPB. £212,008. 2010
2. Early parenting interventions for families with young children showing severe attachment problems: an integrated evidence synthesis. HTA, £238,000, 2011
3. The NEON study: Does home oxygen therapy (HOT) in addition to standard care improve disease severity and symptoms in chronic heart failure? HTA. £1,208,901. 2011
4. Improving care for people with dementia: development and initial feasibility study for evaluation of life story work in dementia care. NIHR Health Services Research Programme, £430,648. 2011
5. Characteristics of unpaid carers for people at the end of their lives – a national survey and an in-depth exploration of the effects of age and socio-economic status on carer-experience. Marie Curie Cancer Care, £161,985. 2011
6. ASSSIST (Autism Spectrum Social Stories In Schools Trial), HTA. £530,937. 2012
7. A feasibility study and pilot trial of computerised cognitive behaviour therapy for depression in adolescents. RfPB. £247,936. 2012
8. Transforming community health services for children and young people who are ill: a quasi-experimental evaluation. NIHR Health Services and Delivery Research Programme. £405,130. 2012
9. Translation of the Strengths and Difficulties Questionnaire into British Sign Language. NIHR. £220,830. 2013
10. Understanding and reducing inequalities for people with cancer: a programme of work based in Yorkshire. Yorkshire Cancer Research. £899,947. 2013
11. Adaptation Validation And Translation of Autism Assessment - Research in Deaf children. MRC Developmental Pathway. £480,016. 2013
12. Home or care? Pathways and outcomes for maltreated children in a multi-ethnic cohort. ESRC, £1,330,160. 2014
13. Mapping and evaluating Specialist Autism Team service models. NIHR Health Services and Delivery Research Programme. £600,000. 2014
14. Morphine for the relief of breathlessness in stable chronic heart failure. British Heart Foundation. £655,288. 2014
15. Recognition of the need for a palliative approach to care for patients with heart failure, COPD or dementia compared to those with cancer using Clinical Practice Research Datalink Academy of Medical Sciences Starter Grant for Clinical Lecturers. £30,000. 2014
16. PLATONOX: Is efficacy of PLAtelet aggregation inhibition by Ticagrelor mediated P2Y12 blockade dependent upon endogenous Endothelial Nitric OXide? Astra Zeneca. £250,000. 2015
17. HIDDEN: Hospice Inpatient Deep vein thrombosis Detection study. Research for Patient Benefit (RfPB) Programme. £295,000. 2015
18. A study of patient acceptance of Two Week Wait urgent referral appointments for suspected cancer. Yorkshire Cancer Research. £173,023. 2015
19. Observing Fibrosis, Macular Atrophy and Sub retinal Highly Reflective Material – Before and After Intervention with Anti-VEGF Treatment: An extension to the EDNA Study. Novartis Pharmaceuticals UK Limited. 2016. £1,327,500. 2016
20. Characterizing hip morphology for patient stratification. White Rose Collaboration Fund. £10,795. 2016
21. Does the use of a clinician-rated needs assessment tool for people with interstitial lung disease reduce the level of unmet patient and carer need? A feasibility study. Marie Curie. £118,682, 2016
22. Reducing inequalities in care for people with cancer and palliative care needs: a programme of work for cancer patients and caregivers in the community based in Yorkshire. Yorkshire Cancer Research. £1,469,537. 2016
23. Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research (Application for release of University of Hull Endowment). Yorkshire Cancer Research. £4,945,546. 2017
24. PEOPLE-HULL: Primary care and community Engagement to Optimise time to Presentation with Lung cancEr symptoms in HULL. Yorkshire Cancer Research. £712,501. 2017
25. A Feasibility, Randomised Controlled Trial Of A Complex Breathlessness Intervention In Idiopathic Pulmonary Fibrosis. NIHR RfPB. £241,170. 2017
26. Autism Spectrum Social Stories In Schools Trial (ASSSIST 2): A randomised controlled trial and economic evaluation of a Social Stories intervention to address the social and emotional health of children with ASD in mainstream primary schools. NIHR HTA. £586,411. 2018
27. Breathlessness RElief AT HomE (BREATHE): A feasibility cluster randomised controlled trial (cRCT) to test if a definitive cRCT is possible to evaluate the effectiveness and cost-effectiveness of a paramedic-administered breathlessness crisis intervention for people with acute-on-chronic breathlessness compared with usual care. NIHR RfPB. £248,603. 2018
I am a member of funding panels responsible for awarding research grants:
- Charitable Trust Scientific Panel for the Chartered Society of Physiotherapy (Sept 2002 – 2018).
- Grant Review Panel for the Multiple Sclerosis Society (July 2014 – Date).
- Health Services Research Initiative Panel for Arthritis UK (April 2016 – 2017) and then Treatment Subcommittee Versus Arthritis (formally Arthritis UK) (November 2017 – Date).
The following are my current membership details of external Trial Steering Committees (TSCs):
- The ECASS Study (Evaluation of a Computer Aid for assessing Stomach Symptoms). Lead University of Durham, Cambridge and Bangor.
- PROVE: Physiotherapy Rehabilitation for Osteoporotic Vertebral Fracture (PROVE) – University of Oxford.
- Trial of Proton Pump Inhibitors in Throat Symptoms: TOPPITS, University of Newcastle upon Tyne.
- FIDELITY: Feasibility of Internet DELivery of Intensive TherapY for children with motor speech disorders and cerebral palsy. University of Newcastle upon Tyne.
- HART: Hughes Abdominal Repair Trial, Cardiff University6. Awareness and Beliefs About Cancer: Phase 3, Cardiff University.